Calcium scoring needed to guide statin prescribing: cardiologists

CVD prevention guidelines should be updated to include the screening tool for low- to intermediate- risk patients, says Professor Tom Marwick.
Rachel Fieldhouse
Professor Tom Marwick.

Australians at low to intermediate risk of cardiovascular disease should undergo calcium scoring to assess their eligibility for statin therapy, according to a study by leading cardiologists. 

Their results suggested more widespread screening would be cost-effective if statins were initiated in patients with a baseline absolute CVD risk of at least 5% and a coronary artery calcium (CAC) score of ≥100 Agatston units (AU).